These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22933244)

  • 1. Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening.
    Lynge E; Njor SH; Olsen AH; Waaseth M; Braaten T; Lund E; Kumle M
    Int J Cancer; 2013 Apr; 132(7):1727. PubMed ID: 22933244
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer mortality in Norway after the introduction of mammography screening.
    Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
    Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening mammography on breast-cancer mortality in Norway.
    Kalager M; Zelen M; Langmark F; Adami HO
    N Engl J Med; 2010 Sep; 363(13):1203-10. PubMed ID: 20860502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [When will mammography screening reduce breast cancer mortality?].
    Strand BH; Zahl PH
    Tidsskr Nor Laegeforen; 2001 Aug; 121(20):2390-2. PubMed ID: 11603048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Does organized mammographic screening reduce the breast cancer mortality?].
    Zahl PH; Strand BH
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):551; author reply 551. PubMed ID: 11961987
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study.
    Olsen AH; Njor SH; Vejborg I; Schwartz W; Dalgaard P; Jensen MB; Tange UB; Blichert-Toft M; Rank F; Mouridsen H; Lynge E
    BMJ; 2005 Jan; 330(7485):220. PubMed ID: 15649904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast cancer mortality versus breast cancer survival].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2010 Feb; 130(3):261. PubMed ID: 20160765
    [No Abstract]   [Full Text] [Related]  

  • 8. Mammography activity in Norway 1983 to 2008.
    Lynge E; Braaten T; Njor SH; Olsen AH; Kumle M; Waaseth M; Lund E
    Acta Oncol; 2011 Oct; 50(7):1062-7. PubMed ID: 21830995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect on breast cancer mortality of population based mammography screening programmes.
    Törnberg S; Carstensen J; Hakulinen T; Lenner P; Hatschek T; Lundgren B
    J Med Screen; 1994 Jul; 1(3):184-7. PubMed ID: 8790514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening and breast cancer mortality in Sweden.
    Autier P; Koechlin A; Smans M; Vatten L; Boniol M
    J Natl Cancer Inst; 2012 Jul; 104(14):1080-93. PubMed ID: 22811439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide mammography screening registers: the best way to go for mortality evaluation - but there is no free lunch.
    Skaane P
    Acta Radiol; 2011 Apr; 52(3):235. PubMed ID: 21498355
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.
    Sankatsing VDV; van Ravesteyn NT; Heijnsdijk EAM; Looman CWN; van Luijt PA; Fracheboud J; den Heeten GJ; Broeders MJM; de Koning HJ
    Int J Cancer; 2017 Aug; 141(4):671-677. PubMed ID: 28457023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammography screening before introduction of the national breast screening programme in Norway.
    Autier P
    Int J Cancer; 2013 Apr; 132(7):1721-2. PubMed ID: 22933058
    [No Abstract]   [Full Text] [Related]  

  • 14. Unreliable Conclusions of Breast Cancer Screening, Incidence, and Mortality--Reply.
    Harding C; Pompei F; Wilson R
    JAMA Intern Med; 2016 Jan; 176(1):141-2. PubMed ID: 26747673
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of the Norwegian breast cancer screening program.
    van Luijt PA; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2017 Feb; 140(4):833-840. PubMed ID: 27861849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is the benefit of organized mass screening for cervix cancer and breast cancer in Norway scientifically justified?].
    Zahl PH
    Tidsskr Nor Laegeforen; 2000 Jun; 120(17):2002-5. PubMed ID: 11008534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic breast cancer screening. Part II. Non-randomised comparisons: results similar to those of randomised trials.
    Prescrire Int; 2015 Apr; 24(159):99-102. PubMed ID: 25941706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.